Evidence map›Paper›PMID 31540812›Full record

ArticleVaccine2019

Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15.

James G Donahue, Burney A Kieke, Jennifer P King, Maria A Mascola, Tom T Shimabukuro, Frank DeStefano, Kayla E Hanson, David L McClure, Oluwatosin Olaiya, Jason M Glanz and 7 more

Open access · hybridAbstract readHistorical Article
In one paragraph

Article in Vaccine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Guideline
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Summary of the National Advisory Committee on Immunization (NACI) Updated Guidance on Influenza Vaccination During Pregnancy.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Information systems for vaccine safety surveillance.Human vaccines & immunotherapeutics · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

James G DonahueMarshfield Clinic Research Institute, 1000 N Oak Ave, Marshfield, WI 54449, United States. Electronic address: donahue.james@mcrf.mfldclin.edu.
Burney A KiekeMarshfield Clinic Research Institute, 1000 N Oak Ave, Marshfield, WI 54449, United States. Electronic address: kieke.burney@marshfieldresearch.org.
Jennifer P KingMarshfield Clinic Research Institute, 1000 N Oak Ave, Marshfield, WI 54449, United States. Electronic address: king.jennifer@marshfieldresearch.org.
Maria A MascolaMarshfield Clinic, Department of Obstetrics and Gynecology, 1000 N Oak Ave, Marshfield, WI 54449, United States. Electronic address: mascola.maria@marshfieldclinic.org.
Tom T ShimabukuroCenters for Disease Control and Prevention, Immunization Safety Office, 1600 Clifton Road NE, MS V18-4 Atlanta, GA 30329, United States. Electronic address: ayv6@cdc.gov.
Frank DeStefanoCenters for Disease Control and Prevention, Immunization Safety Office, 1600 Clifton Road NE, MS V18-4 Atlanta, GA 30329, United States. Electronic address: fxd1@cdc.gov.
Kayla E HansonMarshfield Clinic Research Institute, 1000 N Oak Ave, Marshfield, WI 54449, United States. Electronic address: hanson.kayla@marshfieldresearch.org.
David L McClureMarshfield Clinic Research Institute, 1000 N Oak Ave, Marshfield, WI 54449, United States. Electronic address: mcclure.david@marshfieldresearch.org.
Oluwatosin OlaiyaMarshfield Clinic Research Institute, 1000 N Oak Ave, Marshfield, WI 54449, United States. Electronic address: olaiya.oluwatosin@marshfieldresearch.org.
Jason M GlanzKaiser Permanente Colorado, 10065 E Harvard Ave, Suite 300, Denver, CO 80231, United States. Electronic address: jason.m.glanz@kp.org.
Rulin C HechterKaiser Permanente Southern California, 100 S Los Robles Ave., 2nd Floor, Pasadena, CA 91101, United States. Electronic address: rulin.c.hechter@kp.org.
Stephanie A IrvingKaiser Permanente Northwest, 3800 N Interstate Ave, Portland, OR 97227, United States. Electronic address: stephanie.a.irving@kpchr.org.
Lisa A JacksonKaiser Permanente Washington, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, United States. Electronic address: lisa.a.jackson@kp.org.
Nicola P KleinKaiser Permanente Northern California, 1 Kaiser Plaza, 16th Floor, Oakland, CA 94612, United States. Electronic address: Nicola.Klein@kp.org.
Allison L NalewayKaiser Permanente Northwest, 3800 N Interstate Ave, Portland, OR 97227, United States. Electronic address: Allison.Naleway@kpchr.org.
Eric S WeintraubCenters for Disease Control and Prevention, Immunization Safety Office, 1600 Clifton Road NE, MS V18-4 Atlanta, GA 30329, United States. Electronic address: eiw8@cdc.gov.
Edward A BelongiaMarshfield Clinic Research Institute, 1000 N Oak Ave, Marshfield, WI 54449, United States. Electronic address: belongia.edward@marshfieldclinic.org.
Marshfield Clinic · USKaiser Permanente · USCenters for Disease Control and Prevention · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

introductionA recent study reported an association between inactivated influenza vaccine (IIV) and spontaneous abortion (SAB), but only among women who had also been vaccinated in the previous influenza season. We sought to estimate the association between IIV administered in three recent influenza seasons and SAB among women who were and were not vaccinated in the previous influenza season.

methodsWe conducted a case-control study over three influenza seasons (2012-13, 2013-14, 2014-15) in the Vaccine Safety Datalink (VSD). Cases (women with SAB) and controls (women with live births) were matched on VSD site, date of last menstrual period, age group, and influenza vaccination status in the previous influenza season. Of 1908 presumptive cases identified from the electronic record, 1236 were included in the main analysis. Administration of IIV was documented in several risk windows, including 1-28, 29-56, and >56 days before the SAB date.

resultsAmong 627 matched pairs vaccinated in the previous season, no association was found between vaccination in the 1-28 day risk window and SAB (adjusted odds ratio (aOR) 0.9; 95% confidence interval (CI) 0.6-1.5). The season-specific aOR ranged from 0.5 to 1.7 with all CIs including the null value of 1.0. Similarly, no association was found among women who were not vaccinated in the previous season; the season-specific aOR in the 1-28 day risk window ranged from 0.6 to 0.7 and the 95% CI included 1.0 in each season. There was no association found between SAB and influenza vaccination in the other risk windows, or when vaccine receipt was analyzed relative to date of conception.

conclusionDuring these seasons we found no association between IIV and SAB, including among women vaccinated in the previous season. These findings lend support to current recommendations for influenza vaccination at any time during pregnancy, including the first trimester.

Indexed as

Abortion, SpontaneousAdolescentAdultCase-Control StudiesFemaleHistory, 21st CenturyHumansInfluenza VaccinesOdds RatioPublic Health SurveillanceSeasonsVaccinationVaccines, InactivatedYoung AdultInfluenza VaccinesVaccines, InactivatedInfluenzaInfluenza vaccinePregnancySpontaneous abortion

Identifiers

PMID31540812
PMCPMC6906603
OpenAlexW2973829310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.